Capricor Therapeutics CAPR Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's total liabilities?
- Capricor Therapeutics (CAPR) reported total liabilities of $47.58M in Q1 2026.
- How has Capricor Therapeutics's total liabilities changed year-over-year?
- Capricor Therapeutics's total liabilities increased by 82.2% year-over-year, from $26.12M to $47.58M.
- What is the long-term trend for Capricor Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Capricor Therapeutics's total liabilities has grown at a 50.9% compound annual growth rate (CAGR), from $6.42M to $50.16M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.